申请人:ARK Diagnostics, Inc.
公开号:US20200240991A1
公开(公告)日:2020-07-30
Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.